Loading clinical trials...
Loading clinical trials...
Pilot Study of Daily Exemestane in Women With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Low Grade Endometrial Cancer
Conditions
Interventions
Exemestane
Laboratory Biomarker Analysis
+2 more
Locations
3
United States
University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
University of Minnesota/Masonic Cancer Center
Minneapolis, Minnesota, United States
University of Wisconsin Carbone Cancer Center - University Hospital
Madison, Wisconsin, United States
Start Date
November 15, 2017
Primary Completion Date
December 13, 2023
Completion Date
August 14, 2025
Last Updated
August 29, 2025
NCT05919264
NCT05969860
NCT06253494
NCT05039801
NCT04704661
NCT06349642
Lead Sponsor
National Cancer Institute (NCI)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions